GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RemeGen Co Ltd (OTCPK:REGMF) » Definitions » Gross Profit

REGMF (RemeGen Co) Gross Profit : $149.6 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is RemeGen Co Gross Profit?

RemeGen Co's gross profit for the six months ended in Jun. 2024 was $78.6 Mil. RemeGen Co's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was $149.6 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. RemeGen Co's gross profit for the six months ended in Jun. 2024 was $78.6 Mil. RemeGen Co's Revenue for the six months ended in Jun. 2024 was $102.0 Mil. Therefore, RemeGen Co's Gross Margin % for the quarter that ended in Jun. 2024 was 77.12%.

RemeGen Co had a gross margin of 77.12% for the quarter that ended in Jun. 2024 => Durable competitive advantage

During the past 6 years, the highest Gross Margin % of RemeGen Co was 95.28%. The lowest was 21.10%. And the median was 70.66%.


RemeGen Co Gross Profit Historical Data

The historical data trend for RemeGen Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RemeGen Co Gross Profit Chart

RemeGen Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial - - 213.01 71.41 115.26

RemeGen Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.08 45.41 44.18 70.95 78.62

Competitive Comparison of RemeGen Co's Gross Profit

For the Biotechnology subindustry, RemeGen Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RemeGen Co's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RemeGen Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where RemeGen Co's Gross Profit falls into.



RemeGen Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

RemeGen Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=150.714 - 35.452
=115.3

RemeGen Co's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=101.955 - 23.332
=78.6

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $149.6 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

RemeGen Co's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=78.6 / 101.955
=77.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


RemeGen Co  (OTCPK:REGMF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

RemeGen Co had a gross margin of 77.12% for the quarter that ended in Jun. 2024 => Durable competitive advantage


RemeGen Co Gross Profit Related Terms

Thank you for viewing the detailed overview of RemeGen Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


RemeGen Co Business Description

Traded in Other Exchanges
Address
58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN
RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of innovative biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat major diseases such as autoimmune diseases, oncology, and ophthalmology. The company has its operations in China and the USA and derives the majority of its revenue from China.

RemeGen Co Headlines

From GuruFocus